Egypt has received over 854,000 coronavirus vaccines through the Covax facility for lower and middle income countries, the World Health Organization said Thursday.
The AstraZeneca vaccines, the first to be provided through COVAX to Egypt, were delivered by plane to Cairo late Wednesday, WHO said in a statement.
Egypt has registered more than 200,000 cases of coronavirus, including some 12,000 deaths.
The health ministry has said frontline health workers, the elderly and people with chronic diseases will be prioritised in the vaccine effort, in line with global guidelines.
WHO said 40 million doses would be provided to Egypt—enough for 20 percent of the country’s 100 million population.
The Covax programme aims to help ensure 20 percent of the population in recipient countries is vaccinated by end-2021.
Egypt began its Covid-19 immunisation programme on January 24, becoming one of the first countries in Africa to begin vaccinating its citizens.
At a virtual press conference held by the WHO’s eastern Mediterranean division, officials acknowledged the organisation faced “challenges” in reaching its 20-percent target.
Difficulties included “creating lines of production… and other logistical challenges to deliver shipments to countries”, said Doctor Ahmed al-Mandhari, WHO’s regional director.
He cited in particular an absence of sufficient “storage facilities”, as some vaccines in the Covax programme—notably Pfizer’s—have to be kept at extremely low temperatures.
This was in addition to “funding and financial challenges”, as well as “competition by rich countries” for doses, a situation that the WHO has warned constrains the efficacy of overall efforts to defeat the mutating virus.
WHO officials pointed to the emergence of two new variants in war-torn Libya, warning they were likely to spread to both urban and rural areas.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Egypt gets hundreds of thousands of vaccines via Covax (2021, April 1)
retrieved 1 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya - October 20, 2021
- Trivitron Healthcare in collaboration with Diagon- Vanguard Diagnostics launches Diagon’s Coagulation range in India - October 20, 2021
- Breast cancer early detection, screening, and management – what we need to know - October 20, 2021
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021